Skip links

Biotechnology Unveils New Product Updates Amid Relentless Company Growth

Updated capabilities and continued growth reflect the brand’s modern approach to life sciences manufacturing JERSEY CITY, N.J., November 7, 2022 – Apprentice, provider of one platform to turn molecules into medicine, today announced the release of new functionality to its Tempo Manufacturing Cloud and stellar Q3 growth despite

Curative Biotechnology Announces Toxicology Studies Under Good Laboratory Practices (GLP) for Metformin Eye Drop Formulations for Treatment of Macular Degeneration

National Eye Institute (NEI) to Collaborate with Curative Biotechnology under Cooperative Research and Development Agreement (CRADA) Boca Raton, FL, May 3, 2022 — Curative Biotechnology, Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for rare diseases and